Hepatitis
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 13, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
No abstract available in PubMed .